Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$601M |
| 2 |
Gilead Sciences
GILD
|
+$574M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
Altria Group
MO
|
+$370M |
| 5 |
WIX.com
WIX
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$581M |
| 2 |
eBay
EBAY
|
+$465M |
| 3 |
Lam Research
LRCX
|
+$300M |
| 4 |
Becton Dickinson
BDX
|
+$267M |
| 5 |
UnitedHealth
UNH
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Financials | 11.82% |
| 3 | Industrials | 8.17% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Ooma
OOMA
$604M
| $1.44M | ﹤0.01% |
111,251
+1,137
| +1% | +$14.5K |
|
3052
Elastic
ESTC
$7.81B
| $1.43M | ﹤0.01% |
16,999
-235,565
| -93% | -$19.9M |
|
3053
Replimune Group
REPL
$1.01B
| $1.43M | ﹤0.01% |
+154,212
| New | +$1.35M |
|
3054
Denali Therapeutics
DNLI
$3.97B
| $1.43M | ﹤0.01% |
+102,033
| New | +$1.44M |
|
3055
Qfin Holdings
QFIN
$1.61B
| $1.42M | ﹤0.01% |
32,794
+10,298
| +46% | +$429K |
|
3056
Relay Therapeutics
RLAY
$4.33B
| $1.42M | ﹤0.01% |
410,896
+38,543
| +10% | +$115K |
|
3057
Grab
GRAB
$14.9B
| $1.42M | ﹤0.01% |
282,010
+169,172
| +150% | +$789K |
|
|
OS
3058
DELISTED
OneStream Inc
OS
| $1.41M | ﹤0.01% |
+49,950
| New | +$1.24M |
|
|
ACH
3059
Accendra Health
ACH
$214M
| $1.41M | ﹤0.01% |
155,326
-13,566
| -8% | -$100K |
|
3060
PUT
Pultegroup
PHM
$25.3B
| $1.41M | ﹤0.01% |
+13,400
| New | +$1.35M |
|
3061
Coastal Financial
CCB
$693M
| $1.4M | ﹤0.01% |
14,503
-2,445
| -14% | -$211K |
|
3062
Nuveen Select Tax-Free Income Portfolio
NXP
$900M
| $1.4M | ﹤0.01% |
99,978
-7,350
| -7% | -$103K |
|
3063
Invesco International BuyBack Achievers ETF
IPKW
$563M
| $1.4M | ﹤0.01% |
28,871
-407,752
| -93% | -$18.8M |
|
3064
Cytek Biosciences
CTKB
$546M
| $1.4M | ﹤0.01% |
412,311
+134,963
| +49% | +$450K |
|
3065
Sturm, Ruger & Co
RGR
$593M
| $1.4M | ﹤0.01% |
38,982
-3,883
| -9% | -$144K |
|
3066
Dillards
DDS
$9.56B
| $1.4M | ﹤0.01% |
3,349
+2,755
| +464% | +$1.03M |
|
3067
Angi Inc
ANGI
$196M
| $1.4M | ﹤0.01% |
+91,599
| New | +$1.32M |
|
|
GDO
3068
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.4M
| $1.4M | ﹤0.01% |
119,207
+10,148
| +9% | +$115K |
|
|
KE
3069
Kimball Electronics
KE
$628M
| $1.4M | ﹤0.01% |
72,600
+17,330
| +31% | +$290K |
|
3070
Paysign
PAYS
$705M
| $1.4M | ﹤0.01% |
193,880
+14,569
| +8% | +$52.2K |
|
3071
Vestis
VSTS
$1.88B
| $1.4M | ﹤0.01% |
243,521
-10,180
| -4% | -$71.5K |
|
3072
Graham Corp
GHM
$1.31B
| $1.39M | ﹤0.01% |
28,163
-1,336
| -5% | -$49.5K |
|
|
PRSU
3073
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
| $1.39M | ﹤0.01% |
48,315
-5,500
| -10% | -$162K |
|
3074
Oil-Dri
ODC
$1.34B
| $1.39M | ﹤0.01% |
23,572
-361
| -2% | -$17.5K |
|
3075
Barrett Business Services
BBSI
$804M
| $1.39M | ﹤0.01% |
33,338
+14,386
| +76% | +$592K |
|
Similar funds
Ameriprise's Q2 2025 Portfolio in Review
As of Q2 2025, Ameriprise held 4,177 positions worth $406B, up 9.5% from $370B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ameriprise's Q2 2025 filing shows 166 new, 1,840 increased, 1,831 reduced and 222 closed positions. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 3,498,838 shares worth $176M. The largest sale was AbbVie, an estimated $581M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Ameriprise's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 3,498,838 shares worth $176M.
- Ameriprise added most to Alphabet (Google) Class A in Q2 2025, an estimated $601M increase.
- Ameriprise's biggest Q2 2025 reduction was AbbVie, cutting an estimated $581M.
- Ameriprise fully exited Discover Financial Services in Q2 2025, selling an estimated $111M.
- Ameriprise's ten largest holdings make up 21% of its $406B portfolio in Q2 2025.
- Ameriprise opened 166 new positions and closed 222 in Q2 2025.
- Ameriprise's portfolio value rose 9.5% quarter-over-quarter to $406B.
Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.